Search Login Register

Picibanil Summary

Description: A lyophilized preparation of a low-virulence strain (SU) of Streptococcus pyogenes (S. hemolyticus), inactivated by heating with penicillin G. It has been proposed as a noncytotoxic antineoplastic agent because of its immune system-stimulating activity.

Also Known As: NSC-B116209; OK-432; Picibanyl; Streptococcal OK-432; Streptococcal Preparation OK-432 Show All >>

Networked: 1009 relevant articles (177 outcomes, 139 trials/studies) for this Bio-Agent

Key Diseases for which Picibanil is Relevant

  1. Neoplasms (Cancer) : 40 outcomes 44 studies in 449 results
  2. Lymphangioma (Cavernous Lymphangioma) : 20 outcomes 11 studies in 65 results
  3. Stomach Neoplasms (Stomach Cancer) : 15 outcomes 21 studies in 108 results
  4. Neoplasm Metastasis (Metastasis) : 15 outcomes 5 studies in 73 results
  5. Cysts : 8 outcomes 5 studies in 29 results
Show All >>

Drugs Related to Picibanil

  1. Picibanil
  2. krestin (PSK)
  3. Interleukin-2 (IL2)
  4. Fluorouracil (Carac)
  5. Tegafur
  6. Fibrinogen (Factor I)
  7. Mitomycin (Mitomycin-C)
  8. Cisplatin (Platino)
  9. Carbazilquinone (Carboquone)
  10. Cyclophosphamide (Cytoxan)
Show All >>

Therapies Related to Picibanil

  1. Immunotherapy
  2. Sclerotherapy
  3. Intralesional Injections
  4. Drug Therapy (Chemotherapy)
  5. Pleurodesis
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.